Cetuximab Monotherapy Maintenance Treatment in mCRC

Clinical trial NCT02978313 · UNKNOWN

Trial details

NCT number: NCT02978313
Sponsor: Ruijin Hospital
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Colorectal Cancer

Start date: 2016-11-01
Primary completion: 2019-11-01
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.